Zoetis
ZTS on NYSE. Zoetis sells animal medicines and vaccines to pet owners, veterinarians, and livestock producers. Market value $29.5bn.
Price checks use the past 12 months to June 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.
The company doesn't report operating profit, so we work it out from pre-tax profit and interest.
Should I look at this?
Worth a closer look
Why it could be worth it
What to watch out for
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $7.74 of spare cash last year. A savings account pays about $4.
You pay 10.5 years of operating profit for the business. The average large US company costs around 18.
Each dollar kept in the business earns 28 cents a year. Above 10 is good.
Quality score: 82 of 100. Price score: 100 of 100. Our list needs 70 on quality and 60 on price.
$71.41 a share, 4% above its 1-year low
Over the past year the price has ranged from $68.77 to $148.30.
Dividend: 3.0% a year
Paid every year for at least 5 years
Prices from Monday’s close (5 October).
Five years of cash, in billions
| Revenue | |||||
| Revenue | $7.8bn | $8.1bn | $8.5bn | $9.3bn | $9.5bn |
| Operating margin | |||||
| Operating margin | 34.9% | 35.6% | 37.2% | 36.3% | 37.8% |
| Debt to equity | |||||
| Debt to equity | 1.45 | 1.79 | 1.32 | 1.38 | 2.72 |
| Shares outstanding | |||||
| Shares outstanding | 0.47bn | 0.46bn | 0.45bn | 0.44bn | 0.41bn |
Health checks
- Free cash flow positive5 of 5 years
- Accounting looks honest (Beneish)Nothing unusual
- Financial strength (Piotroski)7 of 9
- Profit backed by cash (accruals)Yes
- Debt2.72× equity
- Revenue growth, five yearsSlow, 7.2% a year
- Buying back its own sharesYes, 11% fewer since 2021
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $2.5 billion last quarter, about the same as a year ago.
- Profit: $691 million, down 5% on a year ago.
- 6% fewer shares than a year ago. Each share owns a bit more of the company.
- Debt is $7.6 billion more than cash, up from $5.1 billion a year ago.
- Sales grew on a year ago in 3 of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $2.4bn |
| December 2024 | $2.3bn |
| March 2025 | $2.2bn |
| June 2025 | $2.5bn |
| September 2025 | $2.4bn |
| December 2025 | $2.4bn |
| March 2026 | $2.3bn |
| June 2026 | $2.5bn |
| Quarter to | Amount |
|---|---|
| September 2024 | $682m |
| December 2024 | $581m |
| March 2025 | $602m |
| June 2025 | $726m |
| September 2025 | $721m |
| December 2025 | $603m |
| March 2026 | $601m |
| June 2026 | $691m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- 3 November 2026
- Last annual report (10-K)
- 12 February 2026
- Next quarterly (estimated, 10-Q)
- 5 November 2026
Who owns it
19 long-term investors we follow own it, unchanged from 19 last quarter. 1,427 funds in all.
- GMOJeremy Grantham
- Value
- $743,392
- Share of fund
- <0.1%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| Diamond Hill Capital ManagementRic Dillon (founder) | $256m | 2.0% | Added |
| Ruane Cunniff & Goldfarb (Sequoia Fund)John Harris | $169m | 2.6% | Cut |
| Brandes Investment PartnersCharles Brandes | $139m | 1.0% | New |
| Smead Capital ManagementBill Smead | $89m | 1.9% | New |
| Scharf InvestmentsBrian Krawez | $53m | 1.7% | Cut |
| Tweedy, BrowneTweedy Browne partners | $40m | 3.0% | New |
| Gotham Asset ManagementJoel Greenblatt | $38m | <0.1% | Added |
| Mairs & PowerAndy Adams | $34m | 0.3% | Added |
| Seilern Investment ManagementPeter Seilern | $33m | 4.2% | Added |
| Polen CapitalDan Davidowitz | $23m | 0.2% | Cut |
| Mawer Investment ManagementMawer team | $18m | 0.1% | Cut |
| Mondrian Investment PartnersMondrian team | $18m | 0.3% | Added |
| First Manhattan Co.First Manhattan partners | $7m | <0.1% | Added |
| Markel GroupTom Gayner | $5m | <0.1% | New |
| Clarkston Capital PartnersJeff Hakala | $1m | <0.1% | Added |
| GAMCO InvestorsMario Gabelli | $891,998 | <0.1% | Cut |
| Cullen Capital ManagementJames Cullen | $801,383 | <0.1% | Added |
| GMOJeremy Grantham | $743,392 | <0.1% | |
| Platinum Investment ManagementPlatinum team | $718,600 | 0.2% | Cut |
Sold out this quarter
Largest holders overall
- BlackRock$2.8bnAdded
- Vanguard Capital Management$1.9bn
- Vanguard Portfolio Management$1.7bn
- State Street$1.4bn
- State Farm Mutual Automobile Insurance$1.1bn
- Geode Capital Management$952mAdded
- Wellington Management Group LLP$677mCut
- Morgan Stanley$638mCut
- Nordea Investment Management AB$472mAdded
- Deutsche Bank AG$421mAdded
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
3 investors own more than 5%.
- BlackRock, Inc.Passive investor9.0%Since 30 June 2026
- Vanguard Capital ManagementPassive investor7.2%Since 31 March 2026
- Vanguard Portfolio ManagementPassive investor5.7%Since 31 March 2026
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
BlackRock, Inc. Passive investor | 9.0% | 30 June 2026 | |
Vanguard Capital Management Passive investor | 7.2% | 31 March 2026 | |
Vanguard Portfolio Management Passive investor | 5.7% | 31 March 2026 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 3 insiders bought $886,384 of shares on the open market. 1 sold $3m, $3m of it under preset trading plans.
- DAMELIO FRANK ADirectorBought
- Date
- 13 May 2026
- Shares
- 6,650
- Price
- $75.39
- Value
- $501,344
- Bisaro PaulDirectorBought
- Date
- 13 May 2026
- Shares
- 2,000
- Price
- $75.88
- Value
- $151,760
- MCCALLISTER MICHAEL BDirectorBought
- Date
- 11 May 2026
- Shares
- 3,000
- Price
- $77.76
- Value
- $233,280
- PECK KRISTIN CChief Executive Officer, DirectorSoldunder a preset trading plan
- Date
- 17 February 2026
- Shares
- 20,000
- Price
- $127.05
- Value
- $3m
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 13 May 2026 | DAMELIO FRANK A Director | Bought | 6,650 | $75.39 | $501,344 |
| 13 May 2026 | Bisaro Paul Director | Bought | 2,000 | $75.88 | $151,760 |
| 11 May 2026 | MCCALLISTER MICHAEL B Director | Bought | 3,000 | $77.76 | $233,280 |
| 17 February 2026 | PECK KRISTIN C Chief Executive Officer, Director | Sold under a preset trading plan | 20,000 | $127.05 | $3m |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 12 Feb 2026, plus the 10-Q filed 6 Aug 2026 and 5 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
- It carries a lot of debt: 2.7× its equity.
Whether the price already reflects the risks is what the deep dive is for.
What changed in the risks this year
Companies must list what could hurt them each year. These are the parts that changed since last year’s report.
The conditional conversion feature of our convertible senior notes, if triggered, may adversely affect our financial condition and operating results.
Could happenIn the event the conditional conversion feature of the convertible senior notes is triggered, holders of convertible senior notes will be entitled to convert the convertible senior notes at any time during specified periods at their option. If one or more holders elect to convert their convertible senior notes, we would be required to settle any converted principal amount of such convertible senior notes through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their convertible senior notes, we would be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the convertible senior notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.
Read moreConversion of our convertible senior notes may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock.
Could happenThe conversion of some or all of the convertible senior notes may dilute the ownership interests of our stockholders. Upon conversion of the convertible senior notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of the convertible senior notes being converted. If we elect to settle the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of the convertible senior notes being converted in shares of our common stock or a combination of cash and shares of our common stock, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the convertible senior notes may encourage short selling by market participants because the conversion of the convertible senior notes could be used to satisfy short positions, or anticipated conversion of the convertible senior notes into shares of our common stock could depress the price of our common stock.
Read moreWe use machine learning and AI in various business operations, and inability to successfully monitor and manage its use could result in operational, competitive or reputational harm, regulatory enforcement, and legal liability.
Could happenWe incorporate (and expect to continue incorporating) AI capabilities in the development of new technologies and products and continue to expand the use of AI in our business and operations. Generative AI technologies are new and rapidly evolving technologies that could deliver significant benefits, but also present a number of operational, compliance, ethical, and reputational risks. AI algorithms are currently known to sometimes generate, among other things, irrelevant, nonsensical, deficient, factually inaccurate, biased or infringing content and results. In addition, if the manners in which we deploy and use AI become controversial, we may experience reputational harm to our brand, competitive harm or legal liability. In addition, we are subject to a growing number of cybersecurity and AI safety laws in markets in which we operate. For example, some of our European operations are subject to NIS2 which imposes cybersecurity requirements on “essential entities.” The EU AI Act prohibits certain AI systems that are categorized as “High Risk,” and requires certain disclosures about the use of AI tools. In the United States, there are emerging state AI laws and regulations that may impose additional requirements and restrictions in connection with the use of AI systems, including their use for "high risk" or "consequential" decision making. These rapidly changing regulatory complexities may increase our compliance costs. Moreover, there is risk that confidential information, including material non-public information, trade secrets or personal identifiable information, is input into AI applications, resulting in such information becoming accessible by third parties, including our competitors.
Read moreWe use machine learning and AI in various business operations, and inability to successfully monitor and manage its use could result in operational, competitive or reputational harm, regulatory enforcement, and legal liability.
Could happenOur competitors may incorporate AI into their operations more quickly or effectively than we do or with more successful outcomes. Additionally, we may not be able to attract or retain the necessary talent to support our AI technology investment or maintain our systems, which may affect our ability to remain competitive. Disruption or failure of our AI systems, or those of various third parties on whom we rely on, could lead to delays and operational challenges, as well as compliance and reputational issues which could materially adversely affect our business, financial condition and results of operations.
Read moreWe use machine learning and AI in various business operations, and inability to successfully monitor and manage its use could result in operational, competitive or reputational harm, regulatory enforcement, and legal liability.
Could happenThe use of AI tools in the development of new technologies and products presents significant IP challenges. Determining IP ownership for AI-generated content remains uncertain in some jurisdictions. Also, AI tools might also unintentionally access or use third party IP or generate output infringing, thereby heightening exposure to IP claims and disputes. Inventions or works of authorship created using AI may be based on or contain, materials that were used in the training of such AI technologies and are identical or similar to third-party intellectual property, which could further limit our ability to obtain intellectual property protection in such inventions or works of authorship.
Read more
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.